Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 1, 2000, Pages 402-409

  Sharkey, A M ^a   Day, K ^a   McPherson, A ^a   Malik, S ^a   Licence, D ^a   Smith, S K ^a   Charnock Jones, D S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; MESSENGER RNA; PROGESTERONE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; HUMAN; HUMAN TISSUE; HYPOXIA; MENSTRUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVASCULARIZATION;

ADULT; ANOXIA; CELL HYPOXIA; CELLS, CULTURED; ENDOMETRIUM; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IN SITU HYBRIDIZATION; LYMPHOKINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROIDS; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034456515     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.1.402     Document Type: Article

References (41)

1. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470
2. Endothelial ceil migratory signal produced by human endometrium during the menstrual cycle
3. Mechanisms of angiogenesis
4. The biology of vascular endothelial growth factor
5. The fins-like tyrosine kinase, a receptor for vascular endothelial growth factor
6. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor
7. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
8. Role of Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
9. Failure of blood-island formation and vascularisation in Flk-1 deficent mice
10. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
11. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
12. In vivo neutralisation of vascular endothelial growth factor inhibits ovarian carcinoma-associated ascites formation and tumour growth
13. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
14. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extrcellular domain of the fit-1 vascular endothelial growth factor receptor
15. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
16. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis
17. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
18. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma ceil lines
19. Two alternative mRNAs coding for the angiogenic growth factor placenta growth factor (P1GF) are transcribed from a single gene of chromosome 14
20. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
21. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth
22. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen
23. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
24. Vascular endothelial growth factor expression in cycling human endometrium
25. Immunolocalisation of Vascular endothelial growth factor in human endometrium
26. Hypoxia stimulates expression of the gene for vascular endothelial growth factor (VEGF), a putative angiogenic factor, by granulosa cells of the ovarian follicle, a site of angiogenesis
27. VEGF act as a survival factor for newly formed retinal vessels, and has implications for retinopathy of prematurity
28. Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma
29. Quantification of mRNA in human tissue using fluorescent nested reverse transcriptase polymerase chain reaction
30. Quantification of mRNA for epidermal growth factyor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction
31. Vascular endothelial growth factor in ocular fluid of patients with diabetic reimopathy and other retinal disorders
32. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
33. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
34. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/ vascular endothelial growth factor
35. The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17β-oestradiol
36. Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo
37. Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines
38. The VEGF isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF
39. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
40. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity
41. Matrix metalloproteinases in normal menstruation